Your session is about to expire
← Back to Search
Group Self-Management Support for Anxiety Disorders
N/A
Waitlist Available
Led By Pasquale Roberge, Ph.D.
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Severe depressive symptoms
Cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups
Awards & highlights
Summary
This trial aims to study if a virtual group self-management support program can help people with anxiety disorders when added to their usual treatment. The study will evaluate the effectiveness and cost of this program compared to standard
Who is the study for?
This trial is for adults over 18 in Quebec who speak French and have been diagnosed with anxiety disorders like Panic Disorder, Agoraphobia, Generalized Anxiety Disorder, or Social Anxiety Disorder. They must have internet access and a device with a microphone and camera to participate.
What is being tested?
The study tests a virtual group self-management support program as an addition to usual care for managing anxiety. It's compared against the standard treatment without this program. The effectiveness will be measured at different intervals up to two years after starting.
What are the potential side effects?
Since the intervention involves educational and self-help strategies rather than medication, no direct medical side effects are expected. Participants may experience discomfort discussing personal experiences or temporary increases in anxiety when confronting their symptoms.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am experiencing severe depression.
Select...
I have trouble with memory or thinking clearly.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Beck Anxiety Inventory (BAI)
Secondary outcome measures
Change in Administrative databases records
Change in Assessment of Quality of Life - 6 Dimensions
Change in Beck Anxiety Inventory
+5 moreOther outcome measures
Gross Cohesion Scale
Working Alliance Inventory
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group self-management supportExperimental Treatment1 Intervention
Group self-management support program for anxiety disorders developped by Relief (https://myrelief.ca/).
Group II: Treatment-as-usualActive Control1 Intervention
Treatment-as-usual and a delayed intervention (if desired by participants) after the 12-month follow up
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
300 Previous Clinical Trials
69,539 Total Patients Enrolled
1 Trials studying Panic Disorder
231 Patients Enrolled for Panic Disorder
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,354 Previous Clinical Trials
26,460,105 Total Patients Enrolled
5 Trials studying Panic Disorder
4,373 Patients Enrolled for Panic Disorder
ReliefUNKNOWN
Share this study with friends
Copy Link
Messenger